Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease

被引：20

作者：

Dachsel, Justus C. ^{[1
]}

Nishioka, Kenya ^{[1
]}

Vilarino-Gueell, Carles ^{[1
]}

Lincoln, Sarah J. ^{[1
]}

Soto-Ortolaza, Alexandra I. ^{[1
]}

Kachergus, Jennifer ^{[1
]}

Hinkle, Kelly M. ^{[1
]}

Heckman, Michael G. ^{[3
]}

Jasinska-Myga, Barbara ^{[1
]}

Taylor, Julie P. ^{[1
]}

Dickson, Dennis W. ^{[2
]}

Gibson, Rachel A. ^{[4
]}

Hentati, Faycal ^{[5
]}

Ross, Owen A. ^{[1
]}

Farrer, Matthew J. ^{[1
]}

机构：

[1] Mayo Clin, Dept Neurosci, Div Neurogenet, Jacksonville, FL 32224 USA

[2] Mayo Clin, Dept Pathol, Jacksonville, FL 32224 USA

[3] Mayo Clin, Coll Med, Biostat Unit, Jacksonville, FL 32224 USA

[4] GlaxoSmithKline, Res & Dev, Harlow, Essex, England

[5] Inst Natl Neurol, Serv Neurol, Tunis, Tunisia

来源：

MECHANISMS OF AGEING AND DEVELOPMENT | 2010年 / 131卷 / 03期

关键词：

LRRK2; PD; Dimerization; Genetics; p.G2019S; KINASE-ACTIVITY; LRRK2; LEUCINE-RICH-REPEAT-KINASE-2; PENETRANCE; VARIANTS; DOMAIN; GENE; ROC;

D O I：

10.1016/j.mad.2010.01.009

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

LRRK2 mutations are recognized as the most frequent genetic cause of both familial and sporadic parkinsonism identified to date. A remarkable feature of this form of parkinsonism is the variable penetrance of symptom manifestation resulting in a wide range of age-at-onset in patients. Herein we use a functional approach to identify the Lrrk1 protein as a potential disease modifier demonstrating an interaction and heterodimer formation with Lrrk2. In addition, evaluation of LRRK1 variants in our large Lrrk2 p.G2019S-parkinsonism series from a Tunisian (n = 145) identified a missense mutation (p.L416M) resulting in an average 6.2 years younger age at disease onset. In conclusion we show that the interaction of Lrrk1-Lrrk2 can form protein dimers and this interaction may influence the age of symptomatic manifestation in Lrrk2-parkinsonism patients. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

引用

页码：210 / 214

页数：5

共 27 条

[1] Roc, a Ras/GTPase domain in complex proteins
Bosgraaf, L
Van Haastert, PJM
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1643 (1-3): : 5 - 10
[2] Digenic parkinsonism:: Investigation of the synergistic effects of PRKN and LRRK2
Dachsel, Justus C.
Mata, Ignacio F.
Ross, Owen A.
Taylor, Julie P.
Lincoln, Sarah J.
Hinkle, Kelly M.
Huerta, Cecilia
Ribacoba, Renee
Blazquez, Marta
Alvarez, Victoria
Farrer, Matthew J.
[J]. NEUROSCIENCE LETTERS, 2006, 410 (02) : 80 - 84
[3] Identification of potential protein interactors of Lrrk2
Daechsel, Justus C.
Taylor, Julie P.
Mok, Su San
Ross, Owen A.
Hinkle, Kelly M.
Bailey, Rachel M.
Hines, Jacob H.
Szutu, Jennifer
Madden, Benjamin
Petrucelli, Leonard
Farrer, Matthew J.
[J]. PARKINSONISM & RELATED DISORDERS, 2007, 13 (07) : 382 - 385
[4] GILLARDON F, 2009, NEUROSCIENCE
[5] The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
Gloeckner, CJ
Kinkl, N
Schumacher, A
Braun, RJ
O'Neill, E
Meitinger, T
Kolch, W
Prokisch, H
Ueffing, M
[J]. HUMAN MOLECULAR GENETICS, 2006, 15 (02) : 223 - 232
[6] The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation
Greggio, Elisa
Zambrano, Ibardo
Kaganovich, Alice
Beilina, Alexandra
Taymans, Jean-Marc
Daniels, Veronique
Lewis, Patrick
Jain, Shushant
Ding, Jinhui
Syed, Ali
Thomas, Kelly J.
Baekelandt, Veerle
Cookson, Mark R.
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (24) : 16906 - 16914
[7] Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1
Greggio, Elisa
Lewis, Patrick A.
van der Brug, Marcel P.
Ahmad, Rili
Kaganovich, Alice
Ding, Jinhui
Beilina, Alexandra
Baker, Acacia K.
Cookson, Mark R.
[J]. JOURNAL OF NEUROCHEMISTRY, 2007, 102 (01) : 93 - 102
[8] The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites
Greggio, Elisa
Taymans, Jean-Marc
Zhen, Eugene Yuejun
Ryder, John
Vancraenenbroeck, Renee
Beilina, Alexandra
Sun, Peng
Deng, Junpeng
Jaffe, Howard
Baekelandt, Veerle
Merchant, Kalpana
Cookson, Mark R.
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 389 (03) : 449 - 454
[9] Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease
Haugarvoll, K.
Rademakers, R.
Kachergus, J. M.
Nuytemans, K.
Ross, O. A.
Gibson, J. M.
Tan, E. -K.
Gaig, C.
Tolosa, E.
Goldwurm, S.
Guidi, M.
Riboldazzi, G.
Brown, L.
Walter, U.
Benecke, R.
Berg, D.
Gasser, T.
Theuns, J.
Pals, P.
Cras, P.
De Deyn, P. Paul
Engelborghs, S.
Pickut, B.
Uitti, R. J.
Foroud, T.
Nichols, W. C.
Hagenah, J.
Klein, C.
Samii, A.
Zabetian, C. P.
Bonifati, V.
Van Broeckhoven, C.
Farrer, M. J.
Wszolek, Z. K.
[J]. NEUROLOGY, 2008, 70 (16) : 1456 - 1460
[10] Variants in the LRRK1 gene and susceptibility to Parkinson's disease in Norway
Haugarvoll, Kristoffer
Toft, Mathias
Ross, Owen A.
White, Linda R.
Aasly, Jan O.
Farrer, Matthew J.
[J]. NEUROSCIENCE LETTERS, 2007, 416 (03) : 299 - 301

← 1 2 3 →